IX Jornada Mineira e XXI Jornada Cento-Oeste de Reumatologia.
DEBATE: A valorização da Reumatologia como especialidade e do título de especialista.
Viviane Angelina de Souza; Georges Basile Christopoulos; Jose Tupinambá Sousa Vasconcelos; Rafael Navarrete Fernandez; Aline Coelho Moreira da Fraga; Marcelo Cruz Rezende; Cleandro Pires de Albuquerque; Vander Fernandes.
MESA DE REVISÃO 01
Mod: Nilzio Antonio; Paulo Madureira.
MESA DE REVISÃO 02
Luiz Severiano Ipsemg; Ana Paula Gomide.
MESA REDONDA 01
Mauricio Raposo Medeiros; Antonio Scafuto.
MESA REDONDA 02
Glaydson Jeronimo da Silva.
MESA REDONDA 03
Luiz Fellipe Genelhu; Adrian Nogueira.
MESA REDONDA 04
Reginaldo Botelho Teodoro; Antonio Carlos Ximenes.
MESA REDONDA 05
Achiles de Almeida Cruz; Hellen Mary da Silveira de Carvalho.

Doenças oportunistas na Reumatologia Voltar

Licia Maria Mota

MESA REDONDA 05 - Achiles de Almeida Cruz; Hellen Mary da Silveira de Carvalho.

Artigo Autor(es) Referência
B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use. Md Yusof Md Yuzaiful, Vital Edward M, Buch Maya H Current rheumatology reports. 2015 Oct; 17(Oct):65. doi: 10.1007/s11926-015-0539-7. pii: .
Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy: A Single Center Study in China. Xue Yu, Jiang Li, Wan Wei-Guo, Chen Yu-Ming, Zhang Jiong, Zhang Zhen-Chun Chinese medical journal. 2016 Feb; 129(Feb):267-73. doi: 10.4103/0366-6999.174490. pii: .
Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature. Jain Archana, Singh Jasvinder A Immunotherapy. 2013 Mar; 5(Mar):265-99. doi: 10.2217/imt.13.10. pii: .
Infection Risk and Safety of Corticosteroid Use. Youssef Jameel, Novosad Shannon A, Winthrop Kevin L Rheumatic diseases clinics of North America. 2016 Feb; 42(Feb):157-76, ix-x. doi: 10.1016/j.rdc.2015.08.004. pii: S0889-857X(15)00068-X.
Infection risk associated with anti-TNF-α agents: a review. Murdaca Giuseppe, Spanò Francesca, Contatore Miriam, Guastalla Andrea, Penza Elena, Magnani Ottavia, Puppo Francesco Expert opinion on drug safety. 2015 Apr; 14(Apr):571-82. doi: 10.1517/14740338.2015.1009036. pii: .
Infectious complications of biological therapy. Haroon Nigil, Inman Robert D Current opinion in rheumatology. 2009 Jul; 21(Jul):397-403. doi: 10.1097/BOR.0b013e32832c792d. pii: .
Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections. Di Franco Manuela, Lucchino Bruno, Spaziante Martina, Iannuccelli Cristina, Valesini Guido, Iaiani Giancarlo International journal of molecular sciences. 2017 01; 18(01):doi: 10.3390/ijms18020293. pii: E293.
Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus. Lertnawapan Ratchaya, Totemchokchyakarn Kitti, Nantiruj Kanokrat, Janwityanujit Suchela Rheumatology international. 2009 Mar; 29(Mar):491-6. doi: 10.1007/s00296-008-0721-6. pii: .
Systematic review of validation studies of the use of administrative data to identify serious infections. Barber Claire, Lacaille Diane, Fortin Paul R Arthritis care & research. 2013 Aug; 65(Aug):1343-57. doi: 10.1002/acr.21959. pii: .

Annals of the rheumatic diseases (8/2017)  

Annals of the rheumatic diseases (7/2017)  

Annals of the rheumatic diseases (10/2017)  

Annals of the rheumatic diseases (6/2017)  

Annals of the rheumatic diseases (11/2017)  

Annals of the rheumatic diseases (6/2018)  

Annals of the rheumatic diseases (7/2018)  

Annals of the rheumatic diseases (4/2018)  

Annals of the rheumatic diseases (1/2018)  

Annals of the rheumatic diseases (3/2018)  

Arthritis & rheumatology (Hoboken, N.J.) (8/2017)  

Nature reviews. Rheumatology (8/2017)  

Nature reviews. Rheumatology (7/2017)